China Price-Gouging Includes 'Huge' Sum For Antibiotic
87 Drugs On NHSA List
Executive Summary
A rare disclosure by China’s national health insurance payer shows how a major state-owned drug maker used its market-dominating position to dodge price-lowering schemes and increase drug prices more than 10-fold.